Thousands of Actos bladder cancer lawsuits could potentially be filed against Takeda Pharmaceuticals, the drug’s manufacturer, following a FDA announcement which linked the Type 2 diabetes drug to a possible increased risk of bladder cancer. Reportedly, the drug’s manufacturer is facing hundreds of Actos bladder cancer lawsuits, which could possibly be filed in courts across the country. Potentially, these Actos bladder cancer lawsuits would allege that the drug triggered the disease, and that the manufacturer failed to warn patients and doctors of this risk.
If you were diagnosed with bladder cancer after taking Actos, ActoPlus Met, ActoPlus Met XR, or Duetact, you may be able to participate in Actos litigation to seek compensation for medical bills and other damages. There is a time limit for filing all Actos bladder cancer lawsuits, however, so do not hesitate to contact our attorneys today by completing our free case review form to find out if you are eligible for legal recourse.
A recent Actos bladder cancer FDA warning has reportedly prompted the wave of potential lawsuits from Actos users who were diagnosed with bladder cancer. On June 15, 2011, the agency announced that use of pioglitazone, an ingredient found in these drugs, for more than a year could put patients at risk for bladder cancer. Due to the possible Actos bladder cancer link, the FDA also approved updated drug labels for Actos and other diabetes medications containing pioglitazone to include information that use of the drug for longer than a year may be associated with an increased risk of bladder cancer. These actions were taken following the agency's review of data which noted an increased risk of bladder cancer among patients with the longest exposure to the pioglitazone, as well as those exposed to the highest cumulative dose.
In light of the FDA's recent actions concerning Actos, our Actos bladder cancer attorneys are available to review claims from users of Actos, ActoPlus Met, ActoPlus Met XR, and Duetact who developed cancerous tumors of the bladder. Potentially, these individuals may be able to participate in an Actos bladder cancer lawsuit to seek compensation for damages, including medical bills and pain and suffering. However, patients should be aware that they only have a certain amount of time, known as the statute of limitations, in which their claim must be filed. Therefore, if you have been diagnosed with bladder cancer after taking Actos, ActoPlus Met, ActoPlus Met XR, or Duetact, contact our Actos litigation attorneys today for a no cost, no obligation review of your claim.
Fill out this form for a FREE, Immediate, Case Evaluation
